Metabolic & Cardiometabolic

statins causes cognitive impairment

In plain terms: Do statins cause cognitive impairment?

Refuted Metabolic & Cardiometabolic 🔬 Includes disconfirming

RefutedContestedStrong support

consensus score -0.74

The directional claim is not supported: blinded RCTs and meta-analyses are largely null/reassuring, finding no consistent adverse effect on cognition.

📅 Last reviewed: 2026-07-14 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

0 support 8 contradict 3 tested null 0 mixed · 11 sources, 8 independent groups

Cochrane agrees with us see how our grade compares ▾

Cochrane · high quality evidence for cognitive function outcome Agrees with our grade

no differences); moderate quality for dementia incidence (downgraded for imprecision)

“There is good evidence that statins given in late life to people at risk of vascular disease do not prevent cognitive decline or dementia. Both trials assessed cognition and found no differences between statin and placebo groups on five different cognitive tests (dementia incidence OR 1.00, 31 vs 31 cases).”

Why we agree: we reached the same direction independently, from our own appraisal of 11 sources. Two methods landing in the same place is a stronger signal than either alone.

What is Cochrane, and why trust it?

Cochrane produces systematic reviews: instead of running a new study, they gather every trial ever done on a question, judge how well each was run, and pool the results. They take no commercial or industry funding, which is why the medical community treats their reviews as a gold standard — and why we check our own verdicts against theirs.

About Cochrane ↗ · Get involved / support ↗

Read the Cochrane review ↗

The evidence (11)

Source	Grade	Stance	Quality	Finding
Heart Protection Study 2002 · Lancet	RCT	tested-null	high	HPS: prospectively assessed cognitive function and found no significant difference between simvastatin and placebo in 20,536 participants.
Ott 2015 · J Gen Intern Med	meta-analysis	contradicts	high	Systematic review/meta-analysis of RCTs: statins did not impair cognition; pooled data showed no significant adverse effect on cognitive performance (directly contradicts the claim).
Shepherd PROSPER 2002 · Lancet	RCT	tested-null	high	PROSPER: in 5,804 elderly, pravastatin had no significant effect on cognitive decline (multiple cognitive tests) versus placebo over 3.2 years.
Novak 2026 · J Alzheimers Dis	observational	contradicts	moderate	Real-world EHR analysis of 125M patients links statin use to lower incident Alzheimer's risk (RR 0.69), not higher.
Richardson 2013 · Ann Intern Med	meta-analysis	contradicts	moderate	Systematic review: found no adverse effect of statins on cognition in good-quality data; cognitive concerns rest mainly on rare anecdotal post-marketing reports.
Ying 2021 · Cardiovasc Drugs Ther	meta-analysis	contradicts	moderate	Meta-analysis of contemporary lipid-lowering agents shows LDL-C lowering does not impair cognitive function.
De Giorgi 2025 · Psychol Med	RCT	tested-null	moderate	28-day randomized simvastatin trial in healthy at-risk adults found no impairment of working memory or reward learning versus placebo.
Adhikari 2021 · J Clin Lipidol	observational	contradicts	moderate	Systematic review of RCTs and cohorts (1.4M participants) finds no adverse cognitive effects or excess dementia with statins in adults >=60.
Liu Y 2026 · Geroscience	meta-analysis	contradicts	high	Narrative review synthesizing RCTs, observational studies, and Mendelian randomization: most RCTs show no harmful cognitive effect of statins, some observational studies suggest protective associations, and MR analyses (>100,000 i
Sternberg Z 2026 · J Prev Alzheimers Dis	observational	contradicts	moderate	NACC cohort study found lipid-lowering regimen (LLR, largely statins) use was associated with reduced yearly increase in CDR-SOB (i.e., slower cognitive/dementia progression) and improved survival, with no adverse effect on neurop
Reddin 2025 · Age Ageing	meta-analysis	contradicts	high	Meta-analysis finds lipid-lowering therapy including statins is not associated with increased cognitive impairment or dementia, if anything trending protective.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.